Senvelgo in Cats

Senvelgo is the brand name for velagliflozin oral solution, a prescription medication approved in the United States for certain cats with diabetes mellitus. It is labeled to improve glycemic control in otherwise healthy cats that have not previously been treated with insulin. That point matters. Senvelgo is not a fit for every diabetic cat, and your vet needs to confirm that your cat is an appropriate candidate before treatment starts.

Unlike insulin, Senvelgo is given by mouth once daily. For some pet parents, that can make home treatment feel more manageable. Still, oral dosing does not mean low-risk treatment. Senvelgo carries an important warning because cats taking it can develop diabetic ketoacidosis, including euglycemic diabetic ketoacidosis, where blood sugar may not look dramatically high even though the cat is very sick. That is why careful screening, early monitoring, and fast action if appetite or energy drops are central parts of safe use.

In FDA approval data, Senvelgo improved blood glucose and fructosamine values and helped many cats show improvement in classic diabetes signs such as increased thirst and urination. Merck Veterinary Manual also notes that oral SGLT2 inhibitors like velagliflozin can rapidly lower glucose and improve clinical signs in newly diagnosed diabetic cats. Even so, treatment choice should be individualized. Some cats are better served with insulin, especially if they have complicating illness, prior insulin exposure, ketones, pancreatitis concerns, or signs suggesting insulin-dependent disease.

For Spectrum of Care planning, Senvelgo is best viewed as one option within a broader diabetes care plan. That plan may also include diet changes, ketone monitoring, follow-up lab work, and sometimes a switch to insulin if the response is incomplete or safety concerns appear. Your vet can help match the treatment path to your cat’s health status, your home routine, and your budget.

Senvelgo belongs to a drug class called SGLT2 inhibitors. These medications work in the kidneys, where they block reabsorption of filtered glucose in the proximal renal tubules. In practical terms, that means more glucose leaves the body in the urine instead of being pulled back into the bloodstream. The result is lower blood glucose and, in many cats, improvement in diabetes-related signs.

This mechanism is very different from insulin. Senvelgo does not replace insulin and does not stimulate the pancreas to make more insulin. Because of that, it can be useful in carefully selected cats with newly diagnosed diabetes that are still making enough insulin to avoid immediate insulin dependence. It also explains why the drug should not be used in cats that have previously received insulin, are currently receiving insulin, or are suspected to have insulin-dependent diabetes mellitus.

Merck notes the labeled dose for velagliflozin is 1 mg/kg by mouth every 24 hours, and the FDA approval summary describes once-daily administration with or without food and regardless of blood glucose level. In the field study used for approval, many cats had meaningful improvement in fructosamine and clinical signs by day 30, and a large proportion maintained improvement over longer follow-up.

Because Senvelgo causes glucosuria, some expected effects line up with how the drug works. Cats may urinate more, drink more, and lose calories through the urine. That can contribute to dehydration or weight loss, especially early on. It also means monitoring cannot rely on blood glucose alone. Your vet may recommend urine or blood ketone checks, repeat chemistry testing, weight checks, and close observation at home during the first week and during any illness.

See your vet immediately if your cat on Senvelgo becomes lethargic, stops eating, vomits repeatedly, seems dehydrated, loses weight quickly, or has weakness or trouble walking. These can be warning signs of diabetic ketoacidosis or euglycemic diabetic ketoacidosis, both of which can be life-threatening. FDA and VCA both emphasize that cats on velagliflozin may develop ketoacidosis even when blood glucose is not severely elevated, which can delay recognition if everyone is focused only on sugar numbers.

In the FDA field study, the most common adverse reactions were diarrhea or loose stool, weight loss, vomiting, polyuria, polydipsia, and elevated blood urea nitrogen. Reported frequencies included diarrhea or loose stool in 52.3% of cats, weight loss in 44%, vomiting in 36.5%, anorexia or hyporexia in 13.5%, dehydration in 11.1%, lethargy in 7.9%, urinary tract infections or cystitis in 7.1%, and diabetic ketoacidosis or euglycemic diabetic ketoacidosis in 7.1%. Some early weight loss likely reflected dehydration and calorie loss from glucosuria.

Not every side effect means the medication must always be stopped forever, but any decline in appetite, energy, hydration, or overall condition needs prompt veterinary guidance. The manufacturer’s management guide advises immediate discontinuation and assessment for ketoacidosis if a cat develops sudden hyporexia, anorexia, lethargy, dehydration, or weight loss. Cats with ketonuria, ketonemia, pancreatitis, anorexia, dehydration, or lethargy at diagnosis should not be started on Senvelgo.

Pet parents should also know that mild gagging or hypersalivation can happen with oral dosing. If the liquid gets on skin or in eyes, rinse well. Keep the bottle secured away from children and other pets. If a dog or another cat accidentally ingests the medication, contact your vet or an emergency clinic right away.

The labeled dose of Senvelgo is 1 mg/kg by mouth once every 24 hours. The FDA approval summary describes this as 0.45 mg/lb once daily. Senvelgo is an oral solution, and the exact milliliter volume depends on your cat’s body weight and the product concentration dispensed. Your vet or pharmacist should show you the correct volume on the dosing syringe for your cat’s current weight.

Senvelgo is given once daily at about the same time each day. It can be given with or without food and does not need to be timed to a blood glucose reading. Many cats do best when the liquid is placed directly into the mouth using the supplied syringe, though some prescriptions may allow dosing on a small amount of food if your vet feels that is reliable. If part of the dose is spit out, do not redose unless your vet specifically tells you to.

This medication should only be started after an appropriate diagnostic workup. That often includes blood glucose, fructosamine, urinalysis, ketone assessment, body weight, and screening for concurrent disease. Cats with prior insulin treatment, current insulin use, suspected insulin-dependent diabetes, ketones, dehydration, lethargy, anorexia, pancreatitis concerns, or significant kidney, liver, or pancreatic disease may need a different plan.

Monitoring is part of dosing. Your vet may recommend rechecks within the first week, then again over the first month, with extra checks during any illness. If you miss a dose, FDA client guidance says to give it the same day when remembered, then continue the regular schedule. If your cat is not eating well, is vomiting, or seems less active, stop the medication and contact your vet right away rather than waiting for the next scheduled visit.

Published veterinary interaction data for Senvelgo are still limited compared with older feline medications. The biggest practical concern is not a long list of classic drug-drug interactions. It is whether other treatments or illnesses change your cat’s hydration status, appetite, ketone risk, or overall metabolic stability. That is why your vet should review every prescription, supplement, and over-the-counter product your cat receives before starting Senvelgo.

Senvelgo has not been evaluated for concurrent use with insulin or other blood glucose-lowering treatments, and it should not be used in cats that have previously been treated with insulin or are currently receiving insulin. Transitioning an insulin-dependent cat off insulin and onto Senvelgo can sharply raise the risk of diabetic ketoacidosis or euglycemic diabetic ketoacidosis. That is a safety issue, not a convenience issue.

Your vet may also be more cautious if your cat is taking medications that can affect kidney function, appetite, fluid balance, or pancreatic health. Diuretics, corticosteroids, appetite-suppressing situations, and drugs used during other illnesses may all change how safe Senvelgo is for a given cat, even if they are not listed as formal label interactions. Cats with suspected urinary tract infection, pancreatitis, liver disease, kidney disease, or other systemic illness may need a different diabetes plan.

The safest approach is to bring a full medication list to every recheck. Include supplements, probiotics, flea and tick products, and any recent emergency treatments. If another clinic sees your cat urgently, tell them your cat is taking Senvelgo so they consider euglycemic ketoacidosis even if the blood glucose is not very high.